Biotech giant Amgen to axe up to 2,900 jobs

Biologic drug-maker Amgen is to shed 12 to 15% of its worldwide workforce and close four sites, despite reporting stellar second-quarter results that trounced Wall Street expectations.

Amgen, which has two facilities in Dublin including the former Pfizer manufacturing plant in Dun Laoghaire, also raised its forecasts for its 2014 profit and revenue, driving up its shares.